Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

Authors not listed

Eisai Korea Inc. · 2015

Abstract

The purpose of the study is for investigation and collection of Aricept safety information with a dose increase on Alzheimer's disease patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Anonymous. (2015). A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients. <em>Eisai Korea Inc.</em>. https://clinicaltrials.gov/study/NCT02158910
Vancouver
Anonymous. A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients. Eisai Korea Inc.. 2015.
BibTeX
@misc{anon2015APlano, title = {A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients}, author = {Anonymous}, journal = {Eisai Korea Inc.}, year = {2015}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings